Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kinexum Metabolics Inc.

Latest From Kinexum Metabolics Inc.

Market Insight - Can ageing be slowed to prevent disease?

The idea of extending the human lifespan has long fascinated the public and challenged scientists. Funding for research into ageing processes, and the R&D of therapeutics to slow them, is increasing. Recent findings suggest that progress has been made, motivated in part by the rapid growth of elderly populations that might benefit from such advances. Furthermore, economists predict that many countries may face bankruptcy by 2050 (or earlier) because of rising healthcare expenditures associated with care of the elderly.

Metabolic Disorders Cardiovascular
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule